AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

Objective The aim of this study was to evaluate the clinical efficacy and safety outcomes of
the treatment with cryoballoon (CB) compared to the treatment with traditional irrigated …

Background Since the release of the second-generation cryoballoon (CB2; Arctic Front
Advance TM, Medtronic Inc) and its design modifications with improved cooling …

Background: Pulmonary vein isolation (PVI) represents the cornerstone in atrial fibrillation
ablation. Cryoballoon and laserballoon catheters have emerged as promising devices but …

Durability of Pulmonary Vein Isolation with Cryoballoon Ablation Introduction Pulmonary
vein (PV) reconnection remains the most important cause of AF recurrence after AF ablation …

Background The second-generation cryoballoon (CB-Adv) is effective in achieving
pulmonary vein isolation (PVI) with encouraging results. The mid-term clinical efficacy of a …

Background The ideal energy dosing remains unclear in second-generation cryoballoon
(CB) pulmonary vein isolation (PVI). We aimed to investigate the effect of an individualized …

Aims To evaluate the effectiveness and safety of cryoballoon ablation (CBA) compared with
radiofrequency ablation (RFA) for symptomatic paroxysmal or drug-refractory persistent …

Aims Whether pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) using
contact force (CF)-guided radiofrequency (RF) or second-generation cryoballoon (CB) …

Background There are 2 Food and Drug Administration–approved catheters (ThermoCool
RF and Arctic Front Advance cryoballoon) for the treatment of drug refractory and …